InsidersTradesSigma
Follow the 국전 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 국전 has logged 106 public disclosures. Market capitalisation: €116.6bn. The latest transaction was disclosed on 1 July 2026 (Other). Among the most active insiders: 홍종호. All data is accessible without an account.
101
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
€5m
2 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,278 of 29,056 companies
25.0
score / 100
Value33
Quality17
FCF yld5.8%
Earn yld-3.3%
EV/EBITDA37.1x
ROE-1.9%
Gross mgn14%
Net mgn-3.3%
Debt/EBITDA9.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations106 total
Other
Other
Other
Other
Other
25 of 106 declarations
关于 국전
국전 是一家在 XKRX 市场上市的公司，专注于医疗保健和制药领域。